Delcath Systems Inc., an interventional oncology company specializing in liver cancer treatments, will participate in the Craig-Hallum 22nd Annual Investor Conference on May 28, 2025, at The Depot Renaissance Hotel in Minneapolis, MN. Further details on what they will present at the event are not provided.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Delcath Systems Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250515839165) on May 15, 2025, and is solely responsible for the information contained therein.